Which of the following is a future application of 3D printing?

Prepare for the Rowan Health Systems Science 1 Test with comprehensive flashcards and multiple choice questions, each with hints and explanations. Excel in your exam preparation!

Multiple Choice

Which of the following is a future application of 3D printing?

Explanation:
The main idea being tested is how 3D printing is expected to be used in medicine in the future. Bioprinting, or printing with living cells to create tissues and organs, represents a future application because it aims to produce actual functional tissue and potentially whole organs for transplantation, personalized to a patient’s biology. This goes beyond printing solid parts or planning aids and into fabricating living structures that could integrate with the body, support regeneration, and be customized to individual patients. Bioprinting uses bio-inks that combine cells with supportive materials to lay down layers that form tissues. If the technology advances, it could address organ shortages and reduce immune rejection by using a patient’s own cells. It also opens doors for personalized drug testing and disease modeling, accelerating development of therapies. However, achieving vascularization to feed thicker tissues, ensuring the printed tissue behaves like native tissue, and meeting safety and regulatory standards are significant challenges to overcome. Other listed applications are already common today: printing prosthetics and dental crowns provides functional parts, and surgical planning models help surgeons visualize complex cases. These are valuable uses of 3D printing now, but they don’t embody the same forward-looking potential as bioprinting for creating living tissues and organs.

The main idea being tested is how 3D printing is expected to be used in medicine in the future. Bioprinting, or printing with living cells to create tissues and organs, represents a future application because it aims to produce actual functional tissue and potentially whole organs for transplantation, personalized to a patient’s biology. This goes beyond printing solid parts or planning aids and into fabricating living structures that could integrate with the body, support regeneration, and be customized to individual patients.

Bioprinting uses bio-inks that combine cells with supportive materials to lay down layers that form tissues. If the technology advances, it could address organ shortages and reduce immune rejection by using a patient’s own cells. It also opens doors for personalized drug testing and disease modeling, accelerating development of therapies. However, achieving vascularization to feed thicker tissues, ensuring the printed tissue behaves like native tissue, and meeting safety and regulatory standards are significant challenges to overcome.

Other listed applications are already common today: printing prosthetics and dental crowns provides functional parts, and surgical planning models help surgeons visualize complex cases. These are valuable uses of 3D printing now, but they don’t embody the same forward-looking potential as bioprinting for creating living tissues and organs.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy